Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

• Status: Not yet recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clínicas Dr. Manuel Quintela
• Collaborators: Centro Cardiovascular Universitario; Centro Hospitalario Pereyra Rossell; University of the Republic, Uruguay
• Treatments: Ibuprofen; Polidocanol

Criteria

Inclusion Criteria:

• Active gynecological age

• Chronic pelvic pain diagnosed by gynecologist of at least 6 months of evolution.

• Transvaginal duplex ultrasound: presence of periuterine varicose veins defined by veins larger than 5mm in diameter with reflux greater than 0.5 seconds on Valsava maneuvers.

Exclusion Criteria:

• Presence of other causes of chronic pelvic pain: endometriosis, pelvic inflammatory disease, postoperative adhesions, uterine myoma, adenomyosis, ovarian tumors, polycystic ovary.

• Fibromyalgia

• BMI greater than 35

• Chronic kidney disease

• thrombophilia

• Alterationof coagulation.

• Allergy to iodinated contrast medium.